New Approach Methodologies Are Here. Is the Industry Ready?

In a recent conversation with a group of operators, we had a real, unfiltered discussion about brain injury: what they’ve experienced and seen in their teammates, what they’ve pushed through, and what it has cost over time.

For patients managing chronic conditions, the appeal of implantable drug delivery is easy to understand: a device placed once, delivering medication precisely where it's needed, for months or years at a time. It's a compelling vision—and for some patients, it's already a reality. For many others, it remains just out of reach.

In Special Operations, cognitive performance is not incidental. It is operational.

Neurotechnology is reaching a turning point, moving from breakthrough research to real‑world impact. In this conversation, Justin Sanchez explores how non‑invasive, wearable neurotech is reshaping rehabilitation, human‑machine interaction, and the future of restoring communication through the nervous system.

MedTech companies are buying their way to innovation. Pharma and biotech are building networks to share the load. Both are responding to the same forces—rising R&D costs, regulatory complexity and pressure to move faster with less—but the strategies couldn't look more different.